Product Name:

NebuSelect™ Recombinant Human CLEC12A/MICL/CLL-1, hFc-tag

Catalog#:

NBL-242807

Description:

NebuSelect™ Recombinant Human CLEC12A/MICL/CLL-1, hFc-tag(Cat#NBL-242807) is expressed in HEK293 with hFc tag at the N-Terminus.It contains His65-Ala265.

Species:

Human

Expression System:

HEK293

Molecular Weight: 

The protein has a predicted MW of 50.9 kDa. Due to glycosylation, the protein migrates to 68-73 kDa based on Bis-Tris PAGE result.

Target Name:

CLEC12A/MICL/CLL-1; MICL; CLL-1; CLEC12A; CLL1; DCAL2; DCAL-2; CD371; CD303; CLECSF11; CLECSF7; DLEC; HECL; PRO34150; DCAL-2

Target Information:

CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML.

Amino Acid Sequence: 

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.